Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001716774-26-000025·Aberdeen Group plc
Schedule 13G ownership disclosure
Corbus Pharmaceuticals Holdings Inc
Common Stock, par value $0.0001 per share · CUSIP: 21833P301
Event date: 2026-09-16
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Aberdeen Group plc
Shares: 0 · Class: 0%
- abrdn Inc.
Shares: 0 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001716774-26-000025
- Form type
- SCHEDULE 13G/A
- Filer
- Aberdeen Group plc
- CIK
- CIK 1716774
- Filed
- Oct 29, 2026
- Reporting period
- Sep 16, 2026
- Description
- Schedule 13G beneficial ownership